Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$10K Sell
272
-2,988
-92% -$106K 0.49% 41
2016
Q4
$113K Buy
3,260
+160
+5% +$5.63K 0.54% 61
2016
Q3
$111K Buy
3,100
+222
+8% +$8.08K 0.55% 49
2016
Q2
$104K Sell
2,878
-486
-14% -$16.6K 0.5% 55
2016
Q1
$106K Buy
+3,364
New +$99.9K 0.46% 70
2015
Q2
Sell
-316
Closed -$10K 203
2015
Q1
$10K Sell
316
-556
-64% -$17K 0.04% 196
2014
Q4
$27K Sell
872
-2,416
-73% -$71.3K 0.11% 167
2014
Q3
$96K Sell
3,288
-494
-13% -$15K 0.4% 109
2014
Q2
$118K Sell
3,782
-212
-5% -$6.61K 0.5% 83
2014
Q1
$126K Buy
3,994
+1,036
+35% +$32.9K 0.56% 62
2013
Q4
$99K Sell
2,958
-1,184
-29% -$38.8K 0.45% 93
2013
Q3
$128K Sell
4,142
-676
-14% -$20.4K 0.64% 44
2013
Q2
$140K Buy
+4,818
New +$131K 0.64% 40

Other funds holding AFL

New York Life Trust's AFL Position: Q1 2017 in Review

New York Life Trust reduced its Aflac (AFL) stake by 92% in Q1 2017, selling an estimated $106K and leaving 272 shares worth $10K. The position accounts for 0.49% of the portfolio, ranked #41.

New York Life Trust first reported a position in AFL in Q2 2013 and has held it in 13 quarters since. The position peaked at $140K in Q2 2013. 909 funds tracked by Wall St. Rank hold AFL as of Q1 2017.

  • New York Life Trust held 272 shares of Aflac worth $10K as of Q1 2017.
  • New York Life Trust sold 2,988 Aflac shares in Q1 2017, an estimated $106K.
  • Aflac made up 0.49% of New York Life Trust's portfolio in Q1 2017, its #41 holding.
  • New York Life Trust first reported a position in Aflac in Q2 2013 and has held it in 13 quarters since.
  • New York Life Trust's Aflac position peaked at $140K in Q2 2013.
  • 909 funds tracked by Wall St. Rank held Aflac as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.